Clinical Trials Sponsored by Park Nicollet Foundation

Total 393 results

HealthPartners Institute
Park Nicollet Foundation

Completed

Impact of Colchicine and Low-dose Naltrexone on COVID-19 (COLTREXONE)

Covid19

United States
HealthPartners Institute
International Diabetes Center at Park Nicollet; Park Nicollet Eating Disorder... and other collaborators

Completed

Support Group Surveys for Individuals Who Have Type 1 Diabetes and an Eating Disorder

Type 1 Diabetes | Eating Disorder

United States
HealthPartners Institute
International Diabetes Center at Park Nicollet; Park Nicollet Eating Disorder... and other collaborators

Completed

Characteristics of Persons With an Eating Disorder and Type 1 Diabetes

Type 1 Diabetes | Eating Disorder

United States
HealthPartners Institute
International Diabetes Center at Park Nicollet; Park Nicollet Eating Disorder... and other collaborators

Completed

Develop and Validate a Self-Administered Instrument That Will Screen for Eating Disorder Symptoms in Persons Aged 12 and Older With Type 1 Diabetes.

Type 1 Diabetes | Eating Disorder

United States
HealthPartners Institute
International Diabetes Center at Park Nicollet; Park Nicollet Foundation

Completed

Barriers to the Implementation of Complete Insulin Order Sets

Hyperglycemia

United States
HealthPartners Institute
International Diabetes Center at Park Nicollet; Park Nicollet Foundation; Melrose...

Terminated

Type 1 Diabetes and Eating Disorder Diurnal Glucose Patterns (REACT5)

Eating Disorder | Type I Diabetes Mellitus Without Complication

United States
HealthPartners Institute
Park Nicollet Eating Disorder Institute

Withdrawn

Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder

Anxiety in Those Patients With Anorexia Nervosa | Eating Disorder Not Otherwise Specified, BMI (<=18)

United States
CeQur Corporation
International Diabetes Center at Park Nicollet

Completed

Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
HealthPartners Institute
Juvenile Diabetes Research Foundation; International Diabetes Center at Park...

Terminated

IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase

Type1diabetes

United States
HealthPartners Institute
Sanofi; International Diabetes Center at Park Nicollet

Completed

Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia

Hyperglycemia

United States
HealthPartners Institute
Sanofi; International Diabetes Center at Park Nicollet

Completed

The Impact of Food on Blood Sugar in People With Type 2 Diabetes (REACT2)

Type 2 Diabetes

United States
HealthPartners Institute
LifeScan; International Diabetes Center at Park Nicollet

Completed

Evaluation of Glucose Monitoring Methods: Characterizing Glycemic Control in Subjects With Diabetes

Diabetes

United States
HealthPartners Institute
Sanofi; International Diabetes Center at Park Nicollet

Completed

Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine

Type 2 Diabetes

United States
HealthPartners Institute
LifeScan; International Diabetes Center at Park Nicollet

Completed

Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
HealthPartners Institute
Roche Diagnostics; International Diabetes Center at Park Nicollet

Completed

Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes (REACT3)

Type 2 Diabetes

United States
HealthPartners Institute
Abbott Diabetes Care; International Diabetes Center at Park Nicollet

Completed

Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food

Type 2 Diabetes | Currently Taking Metformin

United States
HealthPartners Institute
Daiichi Sankyo, Inc.; International Diabetes Center at Park Nicollet

Completed

Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
HealthPartners Institute
Abbott Diabetes Care; International Diabetes Center at Park Nicollet

Completed

Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring

Type 2 Diabetes

United States
HealthPartners Institute
National Institute of Mental Health (NIMH); Essentia Health; Park Nicollet Clinic

Completed

Reducing Cardiovascular Risk in Adults With Serious Mental Illness (SMIWizard)

Schizophrenia | Bipolar Disorder | Chronic Disease | Health Behavior | Mental Disorder

United States
ResMed
Royal North Shore Hospital; International Diabetes Center at Park Nicollet; Baker...

Completed

GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes

Diabetes Mellitus Type 2

United States, Australia, Canada
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI); Park Nicollet Clinic; Hennepin...

Completed

SDM for Stroke Prevention in Atrial Fibrillation (SDM4Afib)

Atrial Fibrillation

United States
St. Paul Heart Clinic
Eli Lilly and Company; Amylin Pharmaceuticals, LLC.; International Diabetes Center...

Completed

The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes

Impaired Glucose Tolerance

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)

Coronary Artery Disease

Korea, Republic of, Taiwan, Thailand, Indonesia, India
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Choice Of Optimal Strategy For Bifurcation Lesions With Normal Side Branch (CROSS)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Optimal Stenting Strategy For True Bifurcation Lesions (PERFECT)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients (ESSENCE-DM2)

Coronary Artery Disease | Diabetes

Korea, Republic of
Seung-Jung Park

Completed

Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease (PRECOMBAT)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions (LONG-DES-V)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Association of Clopidogrel Therapy and Stent Thrombosis (REAL-LATE)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent (DES-ISR)

In-stent Restenosis

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III) (LONG-DES-III)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Recruiting

Observational Study for Left Main Disease Treatment (IRIS-MAIN)

Coronary Artery Disease

Korea, Republic of, China, Malaysia, Taiwan, Thailand
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Statin and Atheroma Vulnerability Evaluation (STABLE)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation (ZEST-LATE)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Focal In-stent Restenosis After Drug-Eluting Stent (FOCUS)

In Stent Restenosis

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Recruiting

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice (IRIS-DES)

Coronary Artery Disease | Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus (ESSENCE-DM)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Withdrawn

Star-Close Versus Angio-Seal for Femoral Artery Hemostasis (CLOSE)

Percutaneous Intervention Via Femoral Artery

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE) (DES-LATE)

Coronary Artery Disease

Korea, Republic of
Centers for Disease Control and Prevention
University of Minnesota; Indiana University; Battelle Memorial Institute; Park...

Completed

Study of In-home Tests for Colorectal Cancer (SIT)

Colorectal Cancer

United States
Nicole Hamblett
Cystic Fibrosis Foundation

Active, not recruiting

The PROMISE Pediatric Study 6 to 11 Years Old

Cystic Fibrosis | Cystic Fibrosis in Children

United States
Nicole Hamblett
Cystic Fibrosis Foundation

Active, not recruiting

A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function (PROMISE)

Cystic Fibrosis

United States
Seung-Jung Park
Dio; CardioVascular Research Foundation, Korea

Completed

Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Completed

Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Terminated

LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
Medtronic; CardioVascular Research Foundation, Korea

Completed

The IRIS-Resolute Integrity (IRIS-Integrity)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
Medtronic; CardioVascular Research Foundation, Korea

Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV) (LONG-DES-IV)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Completed

Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis (PRE-COMBAT 2)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Completed

Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)

Coronary Artery Disease

Korea, Republic of

Clinical Trials Sponsored by Park Nicollet Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations